Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Harald H. Reinhart"'
Omadacycline is a derivative of minocycline and the first agent of the aminomethylcycline class. A total of 3,282 organisms (1 per patient) were consecutively collected from patients hospitalized in China (including Hong Kong) and Taiwan. Susceptibil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca1223fb59eeca2d4b1bed56e7de298
https://europepmc.org/articles/PMC6395890/
https://europepmc.org/articles/PMC6395890/
Autor:
Harald H. Reinhart, Joseph S. Solomkin, H. Simms, H. Bjornson, Ori D. Rotstein, Carol S. Hill, Stephen B. Vogel, Daniel Haverstock, Roger Echols, Holly Coulter, John M.A. Bohnen, E. P. Dellinger
Publikováno v:
Annals of Surgery. 223:303-315
ObjectiveIn a randomized, double-blind, multicenter trial, ciprofloxacin/metronidazole was compared with imipenem/cilastatin for treatment of complicated intra-abdominal infections. A secondary objective was to demonstrate the ability to switch respo
Publikováno v:
Journal of Infectious Diseases. 164:404-406
Mannose residues on the outer membranes of polymorphonuclear leukocytes (PMNL) are capable of binding mannose-sensitive Escherichia coli. Tamm-Horsfall protein, a major urinary glycoprotein, has also been shown to bind mannose-sensitive E. coli via m
Autor:
Harald H. Reinhart, Ori D. Rotstein, Daniel Haverstock, Joseph S. Solomkin, E. Patchen Dellinger, Stephen B. Vogel, John M.A. Bohnen, Robert J. Burnett
Publikováno v:
Surgery. 118(4)
The role of enterococcus in intraabdominal infection is controversial. This study examines the contribution of enterococcus to adverse outcome in a large intraabdominal infection trial.A randomized prospective double-blind trial was performed to comp
Publikováno v:
Gastroenterology. 102(4 Pt 1)
Nitrofurantoin is an antibiotic commonly used for prophylaxis and treatment of urinary tract infections. Pulmonary and hepatic toxicity are rare side effects of this agent. The simultaneous occurrence of pulmonary fibrosis and chronic active hepatiti
Autor:
Oksana M. Korzeniowski, Nora Obedeanu, Donald Kaye, Harald H. Reinhart, Jack D. Sobel, Raida Robinson
Publikováno v:
The Journal of urology. 146(3)
The incidence of urinary tract infection is higher in the geriatric population than in younger adults despite the exclusion of patients with known risk factors. Tamm-Horsfall protein, a renal glycoprotein excreted in urine, may constitute a natural d
Publikováno v:
The Journal of infectious diseases. 162(6)
In quantitative experiments using ELISA, binding of Tamm-Horsfall protein (THP) to uropathogenic Escherichia coli was studied with monoclonal antibody to THP. Adherence to E. coli bearing type 1 fimbriae was proportional to THP concentration and size
Publikováno v:
Reviews of infectious diseases. 11(2)
There is now convincing evidence that Streptococcus milleri is an important cause of pyogenic liver abscesses. The clinical course is no different from that of pyogenic infections of the liver arising from other causes. A positive blood culture shoul
Publikováno v:
The American journal of medicine. 84(2)
A case of Trichosporon beigelii prosthetic valve endocarditis is described. Prosthetic valve endocarditis developed in the patient, a 58-year-old woman with a history of rheumatic heart disease, 10 months after mitral valve surgery. A large left atri
Autor:
Jing S; Beijing Anzhen Hospital, Capital Medical University, Beijing, China., Zhang Y; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Lin Y; Beijing Anzhen Hospital, Capital Medical University, Beijing, China., Gu X; Zai Lab (Shanghai) Co., Ltd, Shanghai, China., Liu J; Zai Lab (Shanghai) Co., Ltd, Shanghai, China., Guglietta A; argenx, Ghent, Belgium., Noukens J; Curare Consulting B.V., Liempde, the Netherlands., Van Bragt T; Curare Consulting B.V., Liempde, the Netherlands., Wang L; Zai Lab (Shanghai) Co., Ltd, Shanghai, China., Chen J; Zai Lab (Shanghai) Co., Ltd, Shanghai, China., Reinhart H; Zai Lab (US) LLC, Cambridge, MA, USA., Pu X; Zai Lab (US) LLC, Cambridge, MA, USA. xia.pu@zailaboratory.com.
Publikováno v:
Drugs in R&D [Drugs R D] 2024 Oct 05. Date of Electronic Publication: 2024 Oct 05.